
Jorge E. Cortes, MD, discusses the frontline treatment options for patients with chronic myeloid leukemia.

Your AI-Trained Oncology Knowledge Connection!


Jorge E. Cortes, MD, discusses the frontline treatment options for patients with chronic myeloid leukemia.

Jorge E. Cortes, MD, discusses the results from the ENESTFreedom study, which evaluated the use of nilotinib as a treatment for patients with BCR-ABL1–positive chronic myeloid leukemia in the chronic phase.<br />

Published: September 5th 2019 | Updated:

Published: June 18th 2019 | Updated: